| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| TXG10x Genomics, Inc. | 2.47B | 21.20 | -13.95 | -1.28% | -11.89% | -9.72% | 0.12 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 71.08M | 146.31M | 245.89M | 298.85M | 490.49M | 516.41M | 618.73M | 610.78M |
| Revenue Growth % | - | 1.06% | 0.68% | 0.22% | 0.64% | 0.05% | 0.2% | -0.01% |
| Cost of Goods Sold | 10.56M | 28.66M | 61.03M | 58.47M | 74.09M | 120.39M | 209.41M | 196.3M |
| COGS % of Revenue | 0.15% | 0.2% | 0.25% | 0.2% | 0.15% | 0.23% | 0.34% | 0.32% |
| Gross Profit | 60.52M | 117.65M | 184.86M | 240.38M | 416.4M | 396.02M | 409.31M | 414.48M |
| Gross Margin % | 0.85% | 0.8% | 0.75% | 0.8% | 0.85% | 0.77% | 0.66% | 0.68% |
| Gross Profit Growth % | - | 0.94% | 0.57% | 0.3% | 0.73% | -0.05% | 0.03% | 0.01% |
| Operating Expenses | 78.9M | 135.47M | 213.93M | 325.7M | 469.31M | 563.97M | 674.64M | 609.04M |
| OpEx % of Revenue | 1.11% | 0.93% | 0.87% | 1.09% | 0.96% | 1.09% | 1.09% | 1% |
| Selling, General & Admin | 46.74M | 87.94M | 130.83M | 202.33M | 257.56M | 298.3M | 343.33M | 344.34M |
| SG&A % of Revenue | 0.66% | 0.6% | 0.53% | 0.68% | 0.53% | 0.58% | 0.55% | 0.56% |
| Research & Development | 32.16M | 47.54M | 83.1M | 123.38M | 211.75M | 265.67M | 270.33M | 264.7M |
| R&D % of Revenue | 0.45% | 0.32% | 0.34% | 0.41% | 0.43% | 0.51% | 0.44% | 0.43% |
| Other Operating Expenses | 137K | -249K | 0 | 0 | 0 | 0 | 60.98M | 0 |
| Operating Income | -18.38M | -110.76M | -29.07M | -85.32M | -52.91M | -167.94M | -265.33M | -194.56M |
| Operating Margin % | -0.26% | -0.76% | -0.12% | -0.29% | -0.11% | -0.33% | -0.43% | -0.32% |
| Operating Income Growth % | - | -5.03% | 0.74% | -1.94% | 0.38% | -2.17% | -0.58% | 0.27% |
| EBITDA | -14.07M | -106.86M | -22M | -66.3M | -24.66M | -134.94M | -221.71M | -150.85M |
| EBITDA Margin % | -0.2% | -0.73% | -0.09% | -0.22% | -0.05% | -0.26% | -0.36% | -0.25% |
| EBITDA Growth % | - | -6.59% | 0.79% | -2.01% | 0.63% | -4.47% | -0.64% | 0.32% |
| D&A (Non-Cash Add-back) | 4.3M | 3.9M | 7.07M | 19.02M | 28.25M | 33.01M | 43.62M | 43.71M |
| EBIT | -17.93M | -109.99M | -27.95M | -532.79M | -52.85M | -161.5M | -248.73M | -177.7M |
| Net Interest Income | -503K | -1.39M | -274K | -150K | -660K | 6.17M | 16.87M | 18.44M |
| Interest Income | 308K | 1.02M | 2.81M | 1.53M | 206K | 6.65M | 16.91M | 18.45M |
| Interest Expense | 811K | 2.41M | 3.08M | 1.68M | 866K | 476K | 33K | 4K |
| Other Income/Expense | -366K | -1.63M | -1.96M | -449.15M | -802K | 5.97M | 16.57M | 16.86M |
| Pretax Income | -18.74M | -112.4M | -31.03M | -534.48M | -53.72M | -161.97M | -248.76M | -177.7M |
| Pretax Margin % | -0.26% | -0.77% | -0.13% | -1.79% | -0.11% | -0.31% | -0.4% | -0.29% |
| Income Tax | 21K | 87K | 218K | 8.26M | 4.51M | 4.03M | 6.34M | 4.93M |
| Effective Tax Rate % | 1% | 1% | 1.01% | 1.02% | 1.08% | 1.02% | 1.03% | 1.03% |
| Net Income | -18.76M | -112.48M | -31.25M | -542.73M | -58.22M | -166M | -255.1M | -182.63M |
| Net Margin % | -0.26% | -0.77% | -0.13% | -1.82% | -0.12% | -0.32% | -0.41% | -0.3% |
| Net Income Growth % | - | -5% | 0.72% | -16.37% | 0.89% | -1.85% | -0.54% | 0.28% |
| Net Income (Continuing) | -18.76M | -112.48M | -31.25M | -542.73M | -58.22M | -166M | -255.1M | -182.63M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.62 | -8.40 | -0.80 | -5.37 | -0.53 | -1.46 | -2.18 | -1.52 |
| EPS Growth % | - | -4.19% | 0.9% | -5.71% | 0.9% | -1.75% | -0.49% | 0.3% |
| EPS (Basic) | -1.62 | -8.40 | -0.80 | -5.37 | -0.53 | -1.46 | -2.18 | -1.52 |
| Diluted Shares Outstanding | 11.59M | 13.39M | 39.09M | 101.15M | 110.35M | 113.86M | 117.17M | 120.45M |
| Basic Shares Outstanding | 11.59M | 13.39M | 39.06M | 101.15M | 110.35M | 113.86M | 117.17M | 120.45M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 68.11M | 106.24M | 480.84M | 774.37M | 747.59M | 635.03M | 596.02M | 584.39M |
| Cash & Short-Term Investments | 47.86M | 65.08M | 424.17M | 663.6M | 587.45M | 429.98M | 388.69M | 393.4M |
| Cash Only | 47.86M | 65.08M | 424.17M | 663.6M | 587.45M | 219.75M | 359.28M | 344.07M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 210.24M | 29.41M | 49.34M |
| Accounts Receivable | 13.34M | 28.09M | 33.37M | 51.21M | 85.25M | 104.21M | 114.83M | 87.86M |
| Days Sales Outstanding | 68.5 | 70.07 | 49.54 | 62.54 | 63.44 | 73.66 | 67.74 | 52.51 |
| Inventory | 4.84M | 8.57M | 15.27M | 29.96M | 59.97M | 81.63M | 73.71M | 83.11M |
| Days Inventory Outstanding | 167.22 | 109.14 | 91.32 | 187.03 | 295.42 | 247.49 | 128.47 | 154.53 |
| Other Current Assets | 2.07M | 0 | 0 | 16.57M | 1.03M | 19.21M | 18.79M | 20.02M |
| Total Non-Current Assets | 7.5M | 18.07M | 125.08M | 154.97M | 271.24M | 393.94M | 369.12M | 334.25M |
| Property, Plant & Equipment | 6.92M | 11.13M | 48.82M | 119.82M | 230.41M | 359.21M | 344.93M | 309.94M |
| Fixed Asset Turnover | 10.26x | 13.15x | 5.04x | 2.49x | 2.13x | 1.44x | 1.79x | 1.97x |
| Goodwill | 0 | 0 | 0 | 0 | 4.51M | 4.51M | 4.51M | 4.51M |
| Intangible Assets | 0 | 0 | 22.37M | 22.35M | 25.4M | 22.86M | 16.62M | 15.67M |
| Long-Term Investments | 0 | 5.01M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 577K | 1.94M | 53.9M | 12.8M | 10.92M | 7.37M | 3.06M | 4.13M |
| Total Assets | 75.61M | 124.31M | 605.92M | 929.34M | 1.02B | 1.03B | 965.14M | 918.64M |
| Asset Turnover | 0.94x | 1.18x | 0.41x | 0.32x | 0.48x | 0.50x | 0.64x | 0.66x |
| Asset Growth % | - | 0.64% | 3.87% | 0.53% | 0.1% | 0.01% | -0.06% | -0.05% |
| Total Current Liabilities | 22.14M | 32.36M | 63.05M | 118.13M | 110.36M | 130.96M | 127.16M | 117.63M |
| Accounts Payable | 5.44M | 8.79M | 13.03M | 4.71M | 17.35M | 21.6M | 15.74M | 12.91M |
| Days Payables Outstanding | 188.13 | 111.97 | 77.91 | 29.4 | 85.48 | 65.49 | 27.43 | 24 |
| Short-Term Debt | 4.22M | 4.19M | 9.88M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 6.72M | 9.2M | 15.56M | 21.63M | 40.91M | 29.74M | 33.96M | 41.84M |
| Current Ratio | 3.08x | 3.28x | 7.63x | 6.56x | 6.77x | 4.85x | 4.69x | 4.97x |
| Quick Ratio | 2.86x | 3.02x | 7.38x | 6.30x | 6.23x | 4.23x | 4.11x | 4.26x |
| Cash Conversion Cycle | 47.59 | 67.24 | 62.94 | 220.17 | 273.38 | 255.66 | 168.78 | 183.03 |
| Total Non-Current Liabilities | 165.98M | 311.94M | 122.79M | 72.14M | 90.9M | 92.28M | 96.94M | 90.87M |
| Long-Term Debt | 6.33M | 25.49M | 19.84M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 57.04M | 76.85M | 86.14M | 83.85M | 73.33M |
| Deferred Tax Liabilities | 158.41M | 284.57M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 514K | 771K | 102.12M | 15.1M | 14.05M | 2.98M | 4.28M | 5.03M |
| Total Liabilities | 188.12M | 344.3M | 185.84M | 190.27M | 201.26M | 223.24M | 224.1M | 208.5M |
| Total Debt | 10.56M | 29.68M | 29.72M | 62.98M | 81.98M | 95.18M | 95.37M | 82.61M |
| Net Debt | -37.3M | -35.4M | -394.45M | -600.63M | -505.47M | -124.57M | -263.91M | -261.45M |
| Debt / Equity | - | - | 0.07x | 0.09x | 0.10x | 0.12x | 0.13x | 0.12x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | -22.66x | -45.98x | -9.44x | -50.73x | -61.10x | -352.82x | -8040.27x | -48639.75x |
| Total Equity | -112.51M | -219.99M | 420.08M | 739.07M | 817.57M | 805.74M | 741.04M | 710.13M |
| Equity Growth % | - | -0.96% | 2.91% | 0.76% | 0.11% | -0.01% | -0.08% | -0.04% |
| Book Value per Share | -9.71 | -16.43 | 10.75 | 7.31 | 7.41 | 7.08 | 6.32 | 5.90 |
| Total Shareholders' Equity | -112.51M | -219.99M | 420.08M | 739.07M | 817.57M | 805.74M | 741.04M | 710.13M |
| Common Stock | 1K | 1K | 2K | 2K | 2K | 2K | 2K | 2K |
| Retained Earnings | -118.63M | -231.12M | -262.37M | -805.1M | -863.32M | -1.03B | -1.28B | -1.47B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -15K | -37K | -46K | -50K | 22K | -4.33M | -429K | -493K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -10.7M | -76.41M | 34.63M | -217.9M | -21.37M | -33.61M | -15.2M | 6.66M |
| Operating CF Margin % | -0.15% | -0.52% | 0.14% | -0.73% | -0.04% | -0.07% | -0.02% | 0.01% |
| Operating CF Growth % | - | -6.14% | 1.45% | -7.29% | 0.9% | -0.57% | 0.55% | 1.44% |
| Net Income | -18.76M | -112.48M | -31.25M | -542.73M | -58.22M | -166M | -255.1M | -182.63M |
| Depreciation & Amortization | 4.3M | 3.9M | 7.07M | 19.02M | 28.25M | 33.01M | 43.62M | 43.71M |
| Stock-Based Compensation | 1.66M | 2.66M | 13.33M | 48.63M | 95.96M | 136.85M | 166.95M | 140.75M |
| Deferred Taxes | 0 | 251K | 614K | 1.55M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 149K | 1.25M | 101K | 306.02M | 79K | 1.96M | 11.99M | 3.58M |
| Working Capital Changes | 1.95M | 28.02M | 44.76M | -50.38M | -87.44M | -39.42M | 17.34M | 1.25M |
| Change in Receivables | -5.13M | -14.75M | -5.28M | -17.85M | -34.04M | -18.95M | -10.61M | 26.95M |
| Change in Inventory | -2M | -3.73M | -6.7M | -14.6M | -30.13M | -21.19M | 7.87M | -9.78M |
| Change in Payables | 3.03M | 2.59M | 4.9M | -7.77M | 11.08M | 5.86M | -6.02M | -3.35M |
| Cash from Investing | -3.76M | -6.71M | -42.77M | -38.39M | -106.73M | -350.89M | 133.49M | -32.63M |
| Capital Expenditures | -3.76M | -6.71M | -42.77M | -38.39M | -101.28M | -131.66M | -48.6M | -12.39M |
| CapEx % of Revenue | 0.05% | 0.05% | 0.17% | 0.13% | 0.21% | 0.25% | 0.08% | 0.02% |
| Acquisitions | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -425K | 0 | 0 | 0 | 0 | -923K | -1M |
| Cash from Financing | 20.58M | 105.37M | 414.59M | 468.91M | 35.3M | 15.82M | 13.67M | 10.91M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - |
| Other Financing | 1.09M | 1.8M | 3.77M | 23.74M | 0 | 0 | 0 | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - |
| Free Cash Flow | -14.46M | -83.12M | -8.14M | -256.29M | -122.65M | -165.27M | -64.72M | -5.73M |
| FCF Margin % | -0.2% | -0.57% | -0.03% | -0.86% | -0.25% | -0.32% | -0.1% | -0.01% |
| FCF Growth % | - | -4.75% | 0.9% | -30.49% | 0.52% | -0.35% | 0.61% | 0.91% |
| FCF per Share | -1.25 | -6.21 | -0.21 | -2.53 | -1.11 | -1.45 | -0.55 | -0.05 |
| FCF Conversion (FCF/Net Income) | 0.57x | 0.68x | -1.11x | 0.40x | 0.37x | 0.20x | 0.06x | -0.04x |
| Interest Paid | 0 | 1.82M | 2.25M | 1.67M | 1.22M | 841K | 436K | 0 |
| Taxes Paid | 0 | 6K | 22K | 280K | 8.66M | 3.92M | 4.93M | 5.64M |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -31.24% | -93.64% | -7.48% | -20.45% | -32.98% | -25.17% |
| Return on Invested Capital (ROIC) | - | - | -85.05% | -78% | -17.62% | -25.36% | -34.36% | -31.52% |
| Gross Margin | 85.14% | 80.41% | 75.18% | 80.44% | 84.89% | 76.69% | 66.15% | 67.86% |
| Net Margin | -26.39% | -76.88% | -12.71% | -181.61% | -11.87% | -32.15% | -41.23% | -29.9% |
| Debt / Equity | - | - | 0.07x | 0.09x | 0.10x | 0.12x | 0.13x | 0.12x |
| Interest Coverage | -22.66x | -45.98x | -9.44x | -50.73x | -61.10x | -352.82x | -8040.27x | -48639.75x |
| FCF Conversion | 0.57x | 0.68x | -1.11x | 0.40x | 0.37x | 0.20x | 0.06x | -0.04x |
| Revenue Growth | - | 105.83% | 68.06% | 21.53% | 64.13% | 5.28% | 19.81% | -1.28% |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Consumables | 206.88M | 252.69M | 418.74M | 435.59M | 479.55M | 493.43M |
| Consumables Growth | - | 22.14% | 65.72% | 4.02% | 10.09% | 2.89% |
| Instruments | - | - | - | - | 123.47M | 92.72M |
| Instruments Growth | - | - | - | - | - | -24.91% |
| Service | 4.07M | 6.03M | 7.28M | 8.43M | 15.7M | 24.64M |
| Service Growth | - | 48.21% | 20.62% | 15.79% | 86.39% | 56.90% |
| Instuments | 34.95M | 40.13M | 64.47M | 72.4M | - | - |
| Instuments Growth | - | 14.83% | 60.67% | 12.29% | - | - |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Americas | - | - | - | - | 373.19M | 347.76M |
| Americas Growth | - | - | - | - | - | -6.81% |
| EMEA | 58M | 73.27M | 108.49M | 117.07M | 142.28M | 159.76M |
| EMEA Growth | - | 26.31% | 48.08% | 7.91% | 21.53% | 12.29% |
| CHINA | 29.92M | 41.74M | 74.92M | 59.56M | 50.97M | 57.3M |
| CHINA Growth | - | 39.51% | 79.50% | -20.51% | -14.43% | 12.43% |
| Asia-Pacific, Excluding China | - | - | 42.09M | - | 52.29M | 45.96M |
| Asia-Pacific, Excluding China Growth | - | - | - | - | - | -12.12% |
| UNITED STATES | - | - | - | 284.99M | - | - |
| UNITED STATES Growth | - | - | - | - | - | - |
| Asia Pacific | 18.21M | 24.51M | - | 46M | - | - |
| Asia Pacific Growth | - | 34.57% | - | - | - | - |
| Americas, Excluding United States | - | - | - | 8.79M | - | - |
| Americas, Excluding United States Growth | - | - | - | - | - | - |
| North America | 139.76M | 159.33M | 258.27M | - | - | - |
| North America Growth | - | 14.01% | 62.10% | - | - | - |
10x Genomics, Inc. (TXG) reported $641.8M in revenue for fiscal year 2024. This represents a 803% increase from $71.1M in 2017.
10x Genomics, Inc. (TXG) saw revenue decline by 1.3% over the past year.
10x Genomics, Inc. (TXG) reported a net loss of $76.3M for fiscal year 2024.
10x Genomics, Inc. (TXG) has a return on equity (ROE) of -25.2%. Negative ROE indicates the company is unprofitable.
10x Genomics, Inc. (TXG) generated $81.7M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.